Auvi-Q FDA Approval History
FDA Approved: Yes (First approved August 10, 2012)
Brand name: Auvi-Q
Generic name: epinephrine
Dosage form: Injection
Company: Sanofi
Treatment for: Anaphylaxis, Allergic Reactions
Auvi-Q (epinephrine injection) is a voice-guided epinephrine auto-injector for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.
Development timeline for Auvi-Q
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
